Fabio Arturo Iannotti

Dr Fabio Arturo Iannotti received his Bachelor Degree in Biotechnology Science (Medical curricula) at the University of Naples “Federico II” in 2006 (with 110/110 cum laude). In 2010, Dr Iannotti graduated with a PhD in Neuroscience at the University of Naples “Federico II”. The focus of his thesis was on the role of voltage-gated potassium channels Kv7 during neuronal excitotoxicity as well as skeletal muscle cell differentiation. During this time he also researched at the University of California-Davis assessing changes to the phosphorylation state of potassium channels in in vivo models of epilepsy. In 2011, he started his postdoc at the Institute of Biomolecular Chemistry (ICB)/ National Council of Research (CNR) and during this period he also visited the University of Reading, researching the potential involvement of TRP channels and cannabinoids in epilepsy and muscle development. Since 2014, he was promoted to the position of research fellow at ICB. In 2018 Dr Iannotti has been qualified as Associate Professor by the Italian Ministry of Education, University and Research (MIUR) in Pharmacology and Molecular Biology areas. Dr Iannotti published many papers on his areas of research in international peer-reviewed journals and has received awards from both national and international scientific societies for his work.

Duchenne’s muscular dystrophy involves a defective transsulfuration pathway activity.

Panza E, Vellecco V, Iannotti FA, Paris D, Manzo OL, Smimmo M, Mitilini N, Boscaino A, de Dominicis G, Bucci M, Di Lorenzo A, Cirino G. Redox Biol. 2021 Sep;45:102040. doi: 10.1016/j.redox.2021.102040. Epub 2021 Jun 19. (I.F. 11.9)

https://pubmed.ncbi.nlm.nih.gov/34174560/

Effects of non-euphoric plant cannabinoids on muscle quality and performance of dystrophic mdx mice. 

Iannotti FA, Pagano E, Moriello AS, Alvino FG, Sorrentino NC, D’Orsi L, Gazzerro E, Capasso R, De Leonibus E, De Petrocellis L, Di Marzo V.Br J Pharmacol. 2019 May;176(10):1568-1584. doi: 10.1111/bph.14460. Epub 2018 Sep 9. (I.F. 8.9)

https://pubmed.ncbi.nlm.nih.gov/30074247/

Genetic and pharmacological regulation of the endocannabinoid CB1 receptor in Duchenne muscular dystrophy

Iannotti FA, Pagano E, Guardiola O… Di Marzo V. Nat Commun. 2018 Sep 27;9(1):3950. doi: 10.1038/s41467-018-06267-1. (I.F. 14.92)

https://pubmed.ncbi.nlm.nih.gov/30262909/

Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability.

Iannotti FA, Hill CL, Leo A, Alhusaini A, Soubrane C, Mazzarella E, Russo E, Whalley BJ, Di Marzo V, Stephens GJ.

ACS Chem Neurosci. 2014 Nov 19;5(11):1131-41. doi: 10.1021/cn5000524. Epub 2014 Jul 29. (I.F. 4.48)

https://pubmed.ncbi.nlm.nih.gov/25029033/

The endocannabinoid 2-AG controls skeletal muscle cell differentiation via CB1 receptor-dependent inhibition of Kv7 channels.

Iannotti FA, Silvestri C, Mazzarella E, Martella A, Calvigioni D, Piscitelli F, Ambrosino P, Petrosino S, Czifra G, Bíró T, Harkany T, Taglialatela M, Di Marzo V.

Proc Natl Acad Sci U S A. 2014 Jun 17;111(24):E2472-81. doi: 10.1073/pnas.1406728111. Epub 2014 Jun 3. (I.F. 11.2)

https://pubmed.ncbi.nlm.nih.gov/24927567/